Charles Schwab Investment Management »

Nektar Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.5M 115k 56.90
2025-06-30 $1.7M 66k 25.84

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Intl (FNDF)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)

View all positions for Charles Schwab Investment Management

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics